WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 3,292.00p on 10-08-2026 at 18:35:05 |
|---|---|
| Change | 27.00p 0.83% |
| Buy | 3,294.00p |
| Sell | 3,292.00p |
| Last Trade: | Sell 118.00 at 3,292.00p |
| Day's Volume: | 300,950 |
| Last Close: | 3,292.00p |
| Open: | 3,271.00p |
| ISIN: | GB00BJFFLV09 |
| Day's Range | 3,262.00p - 3,301.00p |
| 52wk Range: | 2,427.00p - 3,352.00p |
| Market Capitalisation: | £4.59b |
| VWAP: | 3,290.0173p |
| Shares in Issue: | 139.35m |
Croda International (CRDA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 118 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 17 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 122 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 244 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 52 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 199 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 83 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 179 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 679 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
| Sell* | 9 | 3,292.00p | SI Trade |
16:35:28 - 10-Aug-26 |
Croda International (CRDA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Aug 2026 9:04 am | RNS | Director/PDMR Shareholding |
| 31st Jul 2026 1:43 pm | RNS | Director/PDMR Shareholding |
| 28th Jul 2026 7:00 am | RNS | Results for the six months ended 30 June 2026 |
| 13th Jul 2026 1:38 pm | RNS | Director/PDMR Shareholding |
| 11th Jun 2026 2:58 pm | RNS | Director/PDMR Shareholding |
| 11th Jun 2026 9:15 am | RNS | Director Declaration |
| 1st Jun 2026 1:46 pm | RNS | Director/PDMR Shareholding |
| 29th May 2026 4:06 pm | RNS | Director/PDMR Shareholding |
| 29th May 2026 3:10 pm | RNS | Director/PDMR Shareholding |
| 29th May 2026 1:53 pm | RNS | Director/PDMR Shareholding |